secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cyclerion Therapeutics, Inc. (CYCN)
CIK:        0001755237
Form:       8-K
Filed at:   2022-09-30T23:59:59+00:00
Accession:  0000950170-22-019124
Event type: leadership
Sentiment:  negative
Materiality: 0.40
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

CSO Andreas Busch resigns effective Sept 30, 2022
-------------------------------------------------

- Andreas Busch, Ph.D. resigned as Chief Scientific Officer, effective Sept 30, 2022.
- Dr. Busch left to pursue another opportunity; no disagreement with Company's operations, policies or practices.
- No successor has been named; search process not disclosed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1755237/000095017022019124/0000950170-22-019124-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1755237/000095017022019124/cycn-20220930.htm
  HTML page:      https://secwatch.observer/filing/0000950170-22-019124

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer